| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.47e-04 | 57 | 36 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.72e-04 | 60 | 36 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.18e-04 | 65 | 36 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.18e-04 | 65 | 36 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.13e-04 | 334 | 36 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | channel activity | 3.20e-04 | 525 | 36 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.23e-04 | 526 | 36 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.32e-04 | 75 | 36 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.59e-04 | 77 | 36 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.91e-04 | 193 | 36 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 4.23e-04 | 17 | 36 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.23e-04 | 197 | 36 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 7.72e-04 | 100 | 36 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 7.81e-04 | 23 | 36 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 9.95e-04 | 1180 | 36 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.31e-03 | 459 | 36 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | transporter activity | 1.76e-03 | 1289 | 36 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.71e-03 | 793 | 36 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.72e-03 | 43 | 36 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.67e-03 | 50 | 36 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.81e-03 | 51 | 36 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | MHC protein binding | 4.90e-03 | 58 | 36 | 2 | GO:0042287 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 4.34e-04 | 18 | 36 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 6.52e-04 | 22 | 36 | 2 | GO:0098691 | |
| Domain | Teashirt_fam | 1.08e-05 | 3 | 36 | 2 | IPR027008 | |
| Domain | Neurotransmitter_ion_chnl_CS | 8.83e-05 | 45 | 36 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 9.43e-05 | 46 | 36 | 3 | PF02932 | |
| Domain | MARCH-like | 1.00e-04 | 8 | 36 | 2 | IPR033275 | |
| Domain | Neur_chan_LBD | 1.01e-04 | 47 | 36 | 3 | PF02931 | |
| Domain | Neur_channel | 1.01e-04 | 47 | 36 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.01e-04 | 47 | 36 | 3 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 1.01e-04 | 47 | 36 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.01e-04 | 47 | 36 | 3 | IPR006029 | |
| Domain | - | 1.01e-04 | 47 | 36 | 3 | 2.70.170.10 | |
| Domain | RINGv | 1.97e-04 | 11 | 36 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 1.97e-04 | 11 | 36 | 2 | PS51292 | |
| Domain | RhoGAP | 2.30e-04 | 62 | 36 | 3 | SM00324 | |
| Domain | RhoGAP | 2.41e-04 | 63 | 36 | 3 | PF00620 | |
| Domain | RHOGAP | 2.53e-04 | 64 | 36 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 2.53e-04 | 64 | 36 | 3 | IPR000198 | |
| Domain | - | 2.53e-04 | 64 | 36 | 3 | 1.10.555.10 | |
| Domain | Nicotinic_acetylcholine_rcpt | 4.26e-04 | 16 | 36 | 2 | IPR002394 | |
| Domain | Znf_RING-CH | 4.82e-04 | 17 | 36 | 2 | IPR011016 | |
| Domain | RINGv | 4.82e-04 | 17 | 36 | 2 | SM00744 | |
| Domain | Rho_GTPase_activation_prot | 6.45e-04 | 88 | 36 | 3 | IPR008936 | |
| Domain | Acetylcholine_rcpt_TM | 8.91e-04 | 23 | 36 | 2 | IPR027361 | |
| Domain | - | 8.91e-04 | 23 | 36 | 2 | 1.20.120.370 | |
| Domain | Homeobox | 1.02e-02 | 234 | 36 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.05e-02 | 236 | 36 | 3 | PS00027 | |
| Domain | HOX | 1.06e-02 | 237 | 36 | 3 | SM00389 | |
| Domain | Homeobox_dom | 1.08e-02 | 239 | 36 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.08e-02 | 239 | 36 | 3 | PS50071 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.56e-05 | 9 | 21 | 2 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.56e-05 | 9 | 21 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.15e-04 | 11 | 21 | 2 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.38e-04 | 12 | 21 | 2 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.38e-04 | 12 | 21 | 2 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.90e-04 | 14 | 21 | 2 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.19e-04 | 15 | 21 | 2 | MM14704 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.21e-03 | 144 | 21 | 3 | MM14501 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.36e-03 | 335 | 21 | 4 | MM14503 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.12e-03 | 175 | 21 | 3 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.45e-03 | 184 | 21 | 3 | M41809 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.87e-03 | 411 | 21 | 4 | M735 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.32e-03 | 205 | 21 | 3 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.60e-03 | 211 | 21 | 3 | MM14502 | |
| Pubmed | Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits. | 1.10e-06 | 2 | 37 | 2 | 22315221 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 19500157 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 27085880 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 24401102 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 21757542 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 25823894 | ||
| Pubmed | Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy. | 1.10e-06 | 2 | 37 | 2 | 24675634 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18704094 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 21831805 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18055561 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23899432 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 28851948 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 21423795 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 24792900 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 27327258 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23606747 | ||
| Pubmed | Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development. | 3.30e-06 | 3 | 37 | 2 | 16631416 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 21911393 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 14973285 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 27503069 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 25068303 | ||
| Pubmed | Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. | 3.30e-06 | 3 | 37 | 2 | 19745106 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23300075 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 38299743 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 20923852 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 27503071 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 20854418 | ||
| Pubmed | Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. | 6.60e-06 | 4 | 37 | 2 | 22396410 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 19117940 | ||
| Pubmed | Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. | 1.10e-05 | 5 | 37 | 2 | 20418888 | |
| Pubmed | FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. | 2.30e-05 | 7 | 37 | 2 | 19343227 | |
| Pubmed | 2.30e-05 | 7 | 37 | 2 | 20231857 | ||
| Pubmed | 3.07e-05 | 8 | 37 | 2 | 15834955 | ||
| Pubmed | 3.95e-05 | 9 | 37 | 2 | 8906617 | ||
| Pubmed | 3.95e-05 | 9 | 37 | 2 | 19228980 | ||
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 20736995 | ||
| Pubmed | 6.02e-05 | 11 | 37 | 2 | 12225896 | ||
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 6.02e-05 | 11 | 37 | 2 | 29791835 | |
| Pubmed | 7.22e-05 | 12 | 37 | 2 | 20584212 | ||
| Pubmed | 9.94e-05 | 14 | 37 | 2 | 19059502 | ||
| Pubmed | 9.94e-05 | 14 | 37 | 2 | 23213462 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.15e-04 | 15 | 37 | 2 | 8838678 | |
| Pubmed | 1.31e-04 | 16 | 37 | 2 | 14722266 | ||
| Pubmed | 1.31e-04 | 16 | 37 | 2 | 19259974 | ||
| Pubmed | 1.67e-04 | 18 | 37 | 2 | 35411049 | ||
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 1.86e-04 | 19 | 37 | 2 | 17373692 | |
| Pubmed | 4.39e-04 | 29 | 37 | 2 | 39289460 | ||
| Pubmed | 4.39e-04 | 29 | 37 | 2 | 20371770 | ||
| Pubmed | 5.35e-04 | 32 | 37 | 2 | 17540176 | ||
| Pubmed | 5.35e-04 | 32 | 37 | 2 | 16516881 | ||
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 6.41e-04 | 35 | 37 | 2 | 19862010 | |
| Cytoband | 19q12 | 1.19e-04 | 20 | 37 | 2 | 19q12 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 1.45e-04 | 11 | 30 | 2 | 60 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.76e-04 | 15 | 30 | 2 | 529 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 3.15e-04 | 16 | 30 | 2 | 173 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.10e-03 | 50 | 30 | 2 | 721 | |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN | 2.83e-05 | 128 | 36 | 4 | M340 | |
| Coexpression | DESCARTES_FETAL_EYE_GANGLION_CELLS | 4.46e-05 | 50 | 36 | 3 | M40185 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP | 5.40e-05 | 151 | 36 | 4 | M6760 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 162 | 37 | 4 | 0cee9ef405765f3f82d0cd7b8adc88f6e9fdbb5c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 181 | 37 | 4 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-05 | 181 | 37 | 4 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-05 | 183 | 37 | 4 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 185 | 37 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 185 | 37 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 37 | 4 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 187 | 37 | 4 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-05 | 193 | 37 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 194 | 37 | 4 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 195 | 37 | 4 | bf750c516e67c45c6b511909dcff934168a7bbef | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.88e-05 | 79 | 37 | 3 | 5c37af70dca7e9847f44d7f5969d4b06c32b4ca0 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.88e-05 | 79 | 37 | 3 | d4f9297084aea33203dd98d7f6f837b6eb00b6c3 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.88e-05 | 79 | 37 | 3 | 75d8cbf8c7a6a4a825143f7d04a604e97bab0fe5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 105 | 37 | 3 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 105 | 37 | 3 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.06e-05 | 105 | 37 | 3 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 113 | 37 | 3 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 113 | 37 | 3 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 113 | 37 | 3 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.99e-04 | 137 | 37 | 3 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.99e-04 | 137 | 37 | 3 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 2.12e-04 | 140 | 37 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 142 | 37 | 3 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-04 | 147 | 37 | 3 | bbc52cbea37a38058436e3fc6fc0777f83404524 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 151 | 37 | 3 | 3d07b79ecbcfad13116f0f2b039bd181a7ffe853 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-04 | 156 | 37 | 3 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-04 | 156 | 37 | 3 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.20e-04 | 161 | 37 | 3 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-04 | 162 | 37 | 3 | f0a92c92c3a6cf9fa11fb279a584e7f328cb7d43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 163 | 37 | 3 | 6ed2a71385e85508ed513282c06440add7cc010c | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 3.37e-04 | 164 | 37 | 3 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 165 | 37 | 3 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 165 | 37 | 3 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-04 | 167 | 37 | 3 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 167 | 37 | 3 | 1a6a48180481f0c13c15bb93d6ff4eeb96a5b9a0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-04 | 167 | 37 | 3 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.68e-04 | 169 | 37 | 3 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | facs-Heart-LV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 170 | 37 | 3 | 4eaa22040e475100061475123aefa32b56481464 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.75e-04 | 170 | 37 | 3 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 170 | 37 | 3 | 60041b2e57e958f300a5bc76851705c8baf297c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-04 | 170 | 37 | 3 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 170 | 37 | 3 | 793dde64f5517538b66de5f461a445c4ad6dd7b3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 174 | 37 | 3 | ccc59416548ed3b783fd7a050ab32076c4296254 | |
| ToppCell | facs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 174 | 37 | 3 | 30c083fe4711735e83dccfd00fcd746ae673d353 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 174 | 37 | 3 | 46d19c1144fff19be682b7ba59d4c3e014f79e15 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 174 | 37 | 3 | 1802a52552256d1e25d8b328ba62dcfe41671900 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-04 | 175 | 37 | 3 | 030f93af5a96848b9118e2a8116e19ddae438d92 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-04 | 175 | 37 | 3 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 176 | 37 | 3 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-04 | 176 | 37 | 3 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-04 | 176 | 37 | 3 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 4.15e-04 | 176 | 37 | 3 | b9ba7026dee2272c0b483dc0cfa39f74b75f1634 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-04 | 177 | 37 | 3 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-04 | 177 | 37 | 3 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.22e-04 | 177 | 37 | 3 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 37 | 3 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-04 | 178 | 37 | 3 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 37 | 3 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-04 | 178 | 37 | 3 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-04 | 178 | 37 | 3 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.29e-04 | 178 | 37 | 3 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-04 | 178 | 37 | 3 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-04 | 180 | 37 | 3 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-04 | 180 | 37 | 3 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-04 | 180 | 37 | 3 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 181 | 37 | 3 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 181 | 37 | 3 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 181 | 37 | 3 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-04 | 181 | 37 | 3 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.57e-04 | 182 | 37 | 3 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.65e-04 | 183 | 37 | 3 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-04 | 183 | 37 | 3 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-04 | 183 | 37 | 3 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 185 | 37 | 3 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 185 | 37 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 185 | 37 | 3 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 4.87e-04 | 186 | 37 | 3 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | tumor_Lung-B_lymphocytes|tumor_Lung / Location, Cell class and cell subclass | 4.87e-04 | 186 | 37 | 3 | a54b368d7921185c583e35b532a6898c5486c2fc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 186 | 37 | 3 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.87e-04 | 186 | 37 | 3 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 187 | 37 | 3 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-04 | 187 | 37 | 3 | 83582c499cda6306fe5f66f2ac97e27ff420e228 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-04 | 188 | 37 | 3 | 0a47de24812c619f6756c9351a413b109128d54f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.10e-04 | 189 | 37 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.10e-04 | 189 | 37 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.18e-04 | 190 | 37 | 3 | ade43d1d1f8909b8526a23152acf3c26f160f836 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-04 | 190 | 37 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | 368C-Lymphocytic-B_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 190 | 37 | 3 | b9abf773525f7bbc87b8c0d4e94e9d18017de82b | |
| ToppCell | 368C-Lymphocytic-B_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 190 | 37 | 3 | 1a016ae2603be5d024ba024faafd725787db8c48 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.18e-04 | 190 | 37 | 3 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| Drug | dimethylphenylpiperazinium | 1.21e-04 | 59 | 37 | 3 | CID000001316 | |
| Drug | Dns-C6-Cho | 1.40e-04 | 11 | 37 | 2 | CID000124728 | |
| Drug | AC1L9NC9 | 1.40e-04 | 11 | 37 | 2 | CID000449642 | |
| Drug | DDMU | 1.40e-04 | 11 | 37 | 2 | CID000098491 | |
| Drug | dihydronereistoxin | 1.40e-04 | 11 | 37 | 2 | CID000121232 | |
| Drug | bipinnatin-B | 1.40e-04 | 11 | 37 | 2 | CID000127363 | |
| Drug | LJP 1082 | 1.40e-04 | 11 | 37 | 2 | CID003037609 | |
| Drug | AC1L9P8C | 1.68e-04 | 12 | 37 | 2 | CID000450864 | |
| Drug | SureCN373116 | 1.68e-04 | 12 | 37 | 2 | CID010085732 | |
| Drug | nereistoxin | 1.98e-04 | 13 | 37 | 2 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 1.98e-04 | 13 | 37 | 2 | CID004392675 | |
| Drug | C-toxiferine-I | 1.98e-04 | 13 | 37 | 2 | CID005089093 | |
| Drug | bipinnatin-C | 1.98e-04 | 13 | 37 | 2 | CID000129977 | |
| Drug | bipinnatin-A | 1.98e-04 | 13 | 37 | 2 | CID000196603 | |
| Drug | 2,3-dichlorooctafluorobutane | 2.31e-04 | 14 | 37 | 2 | CID000078982 | |
| Drug | LNF 209 | 2.31e-04 | 14 | 37 | 2 | CID000132666 | |
| Drug | aa373 | 2.66e-04 | 15 | 37 | 2 | CID000191672 | |
| Drug | (-)-pictamine | 2.66e-04 | 15 | 37 | 2 | CID006918623 | |
| Drug | (-)-lepadin B | 2.66e-04 | 15 | 37 | 2 | CID006918624 | |
| Drug | SAD-128 | 2.66e-04 | 15 | 37 | 2 | CID000162008 | |
| Drug | anatoxin-a hydrochloride | 2.66e-04 | 15 | 37 | 2 | CID000135265 | |
| Drug | UB-165 | 2.66e-04 | 15 | 37 | 2 | CID004694339 | |
| Drug | N-methylcytisine | 2.66e-04 | 15 | 37 | 2 | CID000234566 | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; PC3; HT_HG-U133A | 2.82e-04 | 196 | 37 | 4 | 6756_UP | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A | 2.82e-04 | 196 | 37 | 4 | 1606_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 6324_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; PC3; HT_HG-U133A | 2.98e-04 | 199 | 37 | 4 | 4648_UP | |
| Drug | AC1L2SVN | 3.04e-04 | 16 | 37 | 2 | CID000127922 | |
| Drug | benzoquinonium | 3.04e-04 | 16 | 37 | 2 | CID000009393 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 3.04e-04 | 16 | 37 | 2 | CID000123866 | |
| Drug | PNU-282,987 | 3.04e-04 | 16 | 37 | 2 | CID004655349 | |
| Drug | scopolamine | 3.04e-04 | 200 | 37 | 4 | CID000005184 | |
| Drug | Nsc36388 | 3.44e-04 | 17 | 37 | 2 | CID000014954 | |
| Drug | neostigmine | 3.81e-04 | 87 | 37 | 3 | CID000004456 | |
| Drug | ABT-594 | 3.87e-04 | 18 | 37 | 2 | CID003075702 | |
| Drug | AC1O8PVM | 3.87e-04 | 18 | 37 | 2 | CID000004989 | |
| Drug | AC1LCVGE | 3.87e-04 | 18 | 37 | 2 | CID000656712 | |
| Drug | benzetimide | 3.87e-04 | 18 | 37 | 2 | CID000021846 | |
| Drug | isoarecolone | 4.32e-04 | 19 | 37 | 2 | CID000146970 | |
| Drug | beta-erythroidine | 4.32e-04 | 19 | 37 | 2 | CID000010074 | |
| Drug | AC1L9P88 | 4.32e-04 | 19 | 37 | 2 | CID000450860 | |
| Drug | perhydrohistrionicotoxin | 4.32e-04 | 19 | 37 | 2 | CID000107881 | |
| Drug | PNU-120596 | 4.32e-04 | 19 | 37 | 2 | CID000311434 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 4.32e-04 | 19 | 37 | 2 | CID000162425 | |
| Drug | pyridostigmine | 4.64e-04 | 93 | 37 | 3 | CID000004991 | |
| Drug | AC1Q5X7V | 4.79e-04 | 20 | 37 | 2 | CID000050190 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 4.79e-04 | 20 | 37 | 2 | CID000001962 | |
| Drug | Dichloride, Alcuronium | 4.79e-04 | 20 | 37 | 2 | CID003032788 | |
| Drug | dinotefuran | 5.29e-04 | 21 | 37 | 2 | CID000197701 | |
| Drug | meproadifen | 5.29e-04 | 21 | 37 | 2 | CID000189752 | |
| Drug | suberyldicholine | 5.82e-04 | 22 | 37 | 2 | CID000123989 | |
| Drug | clothianidin | 5.82e-04 | 22 | 37 | 2 | CID000213027 | |
| Drug | AR-R17779 | 5.82e-04 | 22 | 37 | 2 | CID005310971 | |
| Drug | histrionicotoxin | 5.82e-04 | 22 | 37 | 2 | CID005282247 | |
| Drug | ivermectin | 5.90e-04 | 101 | 37 | 3 | CID006435110 | |
| Drug | ABT-418 | 6.36e-04 | 23 | 37 | 2 | CID000119380 | |
| Drug | AC1L3BL8 | 6.36e-04 | 23 | 37 | 2 | CID000086457 | |
| Drug | alpha-conotoxin SI | 6.36e-04 | 23 | 37 | 2 | CID000163979 | |
| Drug | Skpymrfamide | 6.36e-04 | 23 | 37 | 2 | CID000132661 | |
| Drug | alpha-conotoxin ImI | 6.36e-04 | 23 | 37 | 2 | CID000133011 | |
| Drug | CID6325740 | 6.36e-04 | 23 | 37 | 2 | CID006325740 | |
| Drug | procyclidine | 6.93e-04 | 24 | 37 | 2 | CID000004919 | |
| Drug | AC1L2IZE | 6.93e-04 | 24 | 37 | 2 | CID000072928 | |
| Drug | intruder | 6.93e-04 | 24 | 37 | 2 | CID000213021 | |
| Drug | anabaseine | 6.93e-04 | 24 | 37 | 2 | CID000018985 | |
| Drug | midazolam | 6.98e-04 | 107 | 37 | 3 | CID000004192 | |
| Drug | anabasine | 7.53e-04 | 25 | 37 | 2 | CID000002181 | |
| Drug | pempidine | 7.53e-04 | 25 | 37 | 2 | CID000006603 | |
| Drug | Cys-pro | 7.53e-04 | 25 | 37 | 2 | CID000194366 | |
| Drug | varenicline | 7.53e-04 | 25 | 37 | 2 | CID000170361 | |
| Drug | PrBCM | 7.53e-04 | 25 | 37 | 2 | CID000037396 | |
| Disease | cocaine use | 8.35e-05 | 11 | 37 | 2 | C3496069 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.00e-04 | 12 | 37 | 2 | C1861063 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.82e-04 | 16 | 37 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Cone-Rod Dystrophy 2 | 6.08e-04 | 29 | 37 | 2 | C3489532 | |
| Disease | Liver Dysfunction | 3.70e-03 | 72 | 37 | 2 | C0086565 | |
| Disease | Liver diseases | 3.70e-03 | 72 | 37 | 2 | C0023895 | |
| Disease | Retinitis pigmentosa | 3.90e-03 | 74 | 37 | 2 | cv:C0035334 | |
| Disease | nicotine dependence | 4.33e-03 | 78 | 37 | 2 | EFO_0003768 | |
| Disease | multiple sclerosis | 6.34e-03 | 594 | 37 | 4 | MONDO_0005301 | |
| Disease | ovarian carcinoma | 7.54e-03 | 321 | 37 | 3 | EFO_0001075 | |
| Disease | Retinitis Pigmentosa | 7.56e-03 | 104 | 37 | 2 | C0035334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAPWVKRLFLQKLPK | 331 | Q05901 | |
| PLTKIAWRAAKPLLM | 381 | P78363 | |
| LWRLMKKVQITKPPP | 846 | Q8N7X0 | |
| KLSLPTRAWEPAMKK | 21 | P35670 | |
| EDALMPPKLRLKRRW | 466 | P41162 | |
| RWLPKKPMRLDKETL | 211 | Q32M45 | |
| ARRRLKKENKMTWPP | 196 | P78413 | |
| WSRIKKILKEGPMLK | 211 | Q5KSL6 | |
| PSRLPVKMWGRTLEK | 6 | A6NK44 | |
| PAKKTDIPWRLKQML | 46 | Q86V87 | |
| IMETKLKPLRKWEKL | 131 | Q5T0T0 | |
| IMETKLKPLRKWEKL | 131 | Q8TCQ1 | |
| TMPRWVKTVFLKLLP | 336 | Q15825 | |
| VMWLKPCKRADIPKR | 3956 | Q8WXX0 | |
| KWKKQKRSPRPPRHM | 226 | Q92538 | |
| EGKPLLKAVMRRWLP | 331 | P13639 | |
| RKPKRKRWTGQVEMP | 21 | P28476 | |
| PVVKRPRKKMKWIPT | 421 | Q96RD6 | |
| VPTIMLLPLTWLSKK | 6 | P03905 | |
| PSRRRKMTKILCKWK | 101 | Q8N328 | |
| LRPPAVTVKKLQKWM | 181 | Q5VT97 | |
| VKKRKKVLSWPFLMR | 51 | Q8N103 | |
| WKPSLGRKVMDILKR | 611 | Q9HB63 | |
| RLKNMIPWPASDRKK | 96 | Q9H3S1 | |
| LLTMDKLWRKRKPPV | 266 | Q9UBT2 | |
| LKKRPKWKRVLPSLL | 571 | Q6ZUB1 | |
| SPLKMPKIKLPSFRW | 4951 | Q8IVF2 | |
| LPRELKPNKKYSWMR | 1446 | O15417 | |
| LWLPRMPQKKKLRSK | 141 | Q96PP4 | |
| RPIKMGWLKKQRSIV | 46 | P42331 | |
| KRPKPMGITWFKISL | 216 | Q2M296 | |
| LTNKLRPIAPKWKVM | 571 | Q9NRE2 | |
| PKRWSKPRKRSLLEM | 251 | Q63HK5 | |
| IERKKWMNIRPLPTK | 751 | Q8IWR0 | |
| RSKPWPMAKKLTELR | 171 | Q8TDI7 | |
| MSSPRLIPLWKDLKL | 1 | Q6ZQQ6 | |
| KTALRPDMWPKSELK | 2131 | Q9Y4A5 | |
| RVRKRWLPKIKSMLP | 446 | Q96BF6 |